Pharmacoeconomics & Success in the Marketplace

PRLog (Press Release) – May 31, 2008 – Wouldn’t it be great if you could answer these 3 questions everytime?, Will a drug be successful?, Will a drug make any money?, Is it worth investing in a drugs’ further development?, In these days of thin pipelines and revenues consolidating into a few products there is high pressure your company’s product managers to be sure that their next product, if not a blockbuster, is at least a winner. However, you will be fully aware that through Pharmacoeconomics, we can go some way to predict the future success of your drug!

But questions still remain

Are Pharmacoeconomics any good?
Do Pharmacoeconomics work?
it’s’s brand new report, answers these questions for you. This new report examines the link between this new developmental tool, the financial success of drug and how decision makers are increasingly using Pharmacoeconomics to make their drug purchases - are you using Pharmacoeconomics successfully?

Currently there are 4 economic factors in a pharmacoeconomic evaluation :

Cost minimisation
Cost effectiveness analysis (CEA)
Cost benefit analysis (CBA)
Cost utility analysis (CUA)
it’s’s Pharmacoeconomics and Success in the Marketplace report, examines these steps and points out their usefulness in a drugs’ commercial viability and market positioning.

The report also tackles crucial issues such as :

Formulary decisions
The current effective structure of Pharmacoeconomics
Data problems in implementing and succeeding in Pharmacoeconomics
The influence of Pharmacoeconomics in the pharmaceutical R&D sector
Global Pharmacoeconomic practice from the major industry players

For more information kindly visit :
http://www.bharatbook.com/detail.asp?id=44655
______________________________________________